Cardiometabolic effects of physical activity interventions for people with schizophrenia

References

• Rossler W, Salize H, van Os J, Riecher-Rossler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuro- psychopharmacol 2005;15(4):399–409
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association, 2000
   Google Scholar
• Lieberman J, Stroup T, Perkins D. The American Psychiatric Publishing Textbook of Schizophrenia, 1th edn. Washington DC: American Psychiatric Publishing, 2006
   Google Scholar
• World Health Organisation. The Global Burden of Disease: 2004 Update. Geneva, 2008
   Google Scholar
• Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000;45(1–2):21–8
   PubMed Web of Science ®Google Scholar
• Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry 1997;171:502–8
   PubMed Web of Science ®Google Scholar
• Casey DE, Haupt DW, Newcomer JW, et al. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry 2004;65(Suppl 7):4–18
   PubMed Web of Science ®Google Scholar
• Newcomer JW. Metabolic syndrome and mental illness. Am J Manag Care 2007;13(7 Suppl):170–7
   PubMed Web of Science ®Google Scholar
• Capasso RM, Lineberry TW, Bostwick JM, Decker PA, St Sauver J. Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950–2005. Schizophr Res 2008; 98(1–3):287–94
   PubMed Web of Science ®Google Scholar
• Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64(10):1123–31
   PubMed Web of Science ®Google Scholar
• Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150(6):1115–21
   PubMed Web of Science ®Google Scholar
• Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med 2006;21(11):1133–7
   PubMed Web of Science ®Google Scholar
• Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007;116(5):317–33
   PubMed Web of Science ®Google Scholar
• Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry 2008;69(4):514–9
   PubMed Web of Science ®Google Scholar
• von Hausswolff-Juhlin Y, Bjartveit M, Lindstrom E, Jones P. Schizophrenia and physical health problems. Acta Psychiatr Scand 2009;(Suppl 438):15–21
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection and Evaluation of High Blood Cholesterol in Adults. Executive summary of the third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486–97
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112(17):2735–52
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23(5):469–80
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24(4):683–9
   PubMed Web of Science ®Google Scholar
• Grundy SM. The changing face of cardiovascular risk. J Am Coll Cardiol 2005;46(1):173–5
   PubMed Web of Science ®Google Scholar
• Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk. Curr Diabetes Rev 2005;1(2):137–43
   PubMedGoogle Scholar
• Lorenzo C, Williams K, Hunt KJ, Haffner SM. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care 2006;29(3):625–30
   PubMed Web of Science ®Google Scholar
• De Hert M, Schreurs V, Vancampfort D, van Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009;8(1):15–22
   PubMed Web of Science ®Google Scholar
• De Hert M, Dekker J, Wood D, Kahl K, Müller H. Cardiovascular disease and diabetes in people with severe mental illness: position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology. Eur Psychiatry 2009;24:412–4
   PubMed Web of Science ®Google Scholar
• Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005;19(Suppl 1):1–93
   Google Scholar
• De Hert M, van Eyck D, de Nayer A. Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring. Int Clin Psychopharmacol 2006;21(Suppl 2):11–15
   PubMed Web of Science ®Google Scholar
• Correll CU, Frederickson AM, Kane JM, Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J Clin Psychiatry 2006;67(4):575–83
   PubMed Web of Science ®Google Scholar
• Correll CU. Balancing efficacy and safety in treatment with antipsychotics. CNS Spectr 2007;12(10 Suppl 17):12–20, 35
   PubMed Web of Science ®Google Scholar
• Allison DB, Newcomer JW, Dunn AL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med 2009;36(4):341–50
   PubMed Web of Science ®Google Scholar
• Sharpe JK, Stedman TJ, Byrne NM, Wishart C, Hills AP. Energy expenditure and physical activity in clozapine use: implications for weight management. Aust N Z J Psychiatry 2006;40(9):810–4
   PubMed Web of Science ®Google Scholar
• Faulkner G, Cohn T, Remington G. Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr Res 2006;82(2–3):225–31
   PubMed Web of Science ®Google Scholar
• Roick C, Fritz-Wieacker A, Matschinger H, et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2007;42(4):268–76
   PubMed Web of Science ®Google Scholar
• Lindamer LA, McKibbin C, Norman GJ, et al. Assessment of physical activity in middle-aged and older adults with schizophrenia. Schizophr Res 2008;104(1–3):294–301
   PubMed Web of Science ®Google Scholar
• Faulkner G, Biddle S. Exercise as an adjunct treatment for schizophrenia: a review of the literature. J Mental Health 1999;8(5):441–57
   Google Scholar
• Faulkner G. Exericse as an adjunct treatment for schizophrenia. In: Faulkner G, Taylor A. (ed) Exercise, Health and Mental Health: Emerging Relationships. London: Routledge, 2005; 27–45
   Google Scholar
• Ellis N, Crone D, Davey R, Grogan S. Exercise interventions as an adjunct therapy for psychosis: a critical review. Br J Clin Psychol 2007;46:95–111
   PubMed Web of Science ®Google Scholar
• Bradshaw T, Lovell K, Harris N. Healthy living interventions and schizophrenia: a systematic review. J Adv Nurs 2005;49(6):634–54
   PubMed Web of Science ®Google Scholar
• Lowe T, Lubos E. Effectiveness of weight management interventions for people with serious mental illness who receive treatment with atypical antipsychotic medications. A literature review. J Psychiatr Ment Health Nurs 2008;15(10):857–63
   PubMed Web of Science ®Google Scholar
• Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 2003;64(5):575–9
   PubMed Web of Science ®Google Scholar
• Hart C. Doing a literature search. A comprehensive guide for the social sciences. London: Sage Publications, 2001
   Google Scholar
• Campbell D, Stanley J. Experimental and Quasi-experimental Designs for Research. Chicago, IL: Rand McNally, 1963
   Google Scholar
• Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52(6):377–84
   PubMed Web of Science ®Google Scholar
• Archie S, Wilson JH, Osborne S, Hobbs H, McNiven J. Pilot study: access to fitness facility and exercise levels in olanzapine- treated patients. Can J Psychiatry 2003;48(9):628–32
   PubMed Web of Science ®Google Scholar
• Vreeland B, Minsky S, Menza M, Rigassio Radler D, Roemheld- Hamm B, Stern R. A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv 2003;54(8):1155–7
   PubMed Web of Science ®Google Scholar
• Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12- month data on a multimodal weight control program. J Clin Psychiatry 2004;65(4):471–7
   PubMed Web of Science ®Google Scholar
• Fogarty M, Happell B, Pinikahana J. The benefits of an exercise program for people with schizophrenia: a pilot study. Psychiatr Rehabil J 2004;28(2):173–6
   PubMed Web of Science ®Google Scholar
• Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs 2005;26(6):661–76
   PubMedGoogle Scholar
• Kalarchian MA, Marcus MD, Levine MD, et al. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 2005;66(8):1058–63
   PubMed Web of Science ®Google Scholar
• varez-Jimenez M, Gonzalez-Blanch C, Vazquez-Barquero JL, et al. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial. J Clin Psychiatry 2006;67(8):1253–60
   PubMed Web of Science ®Google Scholar
• Centorrino F, Wurtman JJ, Duca KA, et al. Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes (Lond) 2006;30(6):1011–6
   PubMed Web of Science ®Google Scholar
• Kwon JS, Choi JS, Bahk WM, et al. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. J Clin Psychiatry 2006;67(4):547–53
   PubMed Web of Science ®Google Scholar
• Wu MK, Wang CK, Bai YM, Huang CY, Lee SD. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv 2007;58(4):544–50
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim YH, Kim YJ, Yoon BW. Enforced physical training promotes neurogenesis in the subgranular zone after focal cerebral ischemia. J Neurol Sci 2008;269(1–2):54–61
   PubMed Web of Science ®Google Scholar
• Wu RR, Zhao JP, Jin H, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008;299(2):185–93
   PubMed Web of Science ®Google Scholar
• Marzolini S, Jensen B, Melville P. Feasibility and effects of a group-based resistance and aerobic exercise program for individuals with severe schizophrenia: a multidisciplinary approach. Mental Health Phys Activity 2009;2(1):29–36
   Google Scholar
• Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, ‘just the facts’ what we know in 2008. part 2. Epidemiology and etiology. Schizophr Res 2008;102:1–18
   PubMed Web of Science ®Google Scholar
• Lundh A, Gotzsche PC. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol 2008;8:22
   PubMed Web of Science ®Google Scholar
• Faulkner G, Cohn TA. Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications. Can J Psychiatry 2006;51(8):502–11
   PubMed Web of Science ®Google Scholar
• Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Schizophr Bull 2007;33(3):654–6
   PubMed Web of Science ®Google Scholar
• Varez-Jimenez M, Hetrick SE, Gonzalez-Blanch C, Gleeson JF, McGorry PD. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 2008;193(2):101–7
   PubMed Web of Science ®Google Scholar
• Melamed Y, Stein-Reisner O, Gelkopf M, et al. Multi-modal weight control intervention for people with persistent mental disorders. Psychiatr Rehabil J 2008;31(3):194–200
   PubMed Web of Science ®Google Scholar
• Allison DB, Mackell JA, McDonnell DD. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Serv 2003;3(54): 565–7
   Web of Science ®Google Scholar
• de Hert M, Peuskens B, van Winkel R, et al. Body weight and self–esteem in patients with schizophrenia evaluated with B-WISE. Schizophr Res 2006;88(1–3):222–6
   PubMed Web of Science ®Google Scholar
• Weiden PJ, Mackell JA, McDonnell DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 2004;66(1):51–7
   PubMed Web of Science ®Google Scholar
• Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993;329:1008–12
   PubMed Web of Science ®Google Scholar
• Brock CM, King DS, Wofford MR, Harrell TK. Exercise, insulin resistance, and hypertension: a complex relationship. Metab Syndr Relat Disord 2005;3(1):60–5
   PubMedGoogle Scholar
• Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009;41(2):459–71
   PubMed Web of Science ®Google Scholar
• Fagard RH. Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc 2001;33(6 Suppl):484–92
   Web of Science ®Google Scholar
• Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001;33(Suppl 6):502–15
   Web of Science ®Google Scholar
• Yates T, Khunti K, Bull F, Gorely T, Davies MJ. The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia 2007;50(6):1116–26
   PubMed Web of Science ®Google Scholar
• Marshall DA, Walizer EM, Vernalis MN. Achievement of heart health characteristics through participation in an intensive lifestyle change program (Coronary Artery Disease Reversal Study). J Cardiopulm Rehabil Prev 2009;29(2):84–94
   PubMed Web of Science ®Google Scholar
• Dishman RK, Buckworth, J. Adherence to physical activity. In: Morgan WP. (ed) Physical Activity and Mental Health. Washington, DC: Taylor & Francis; 64–80
   Google Scholar
• American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologist, the North American Association for the Study of Obesity. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 2004;27:596–601
   PubMed Web of Science ®Google Scholar
• Richardson C, Faulkner G, McDevitt J, Skrinar G, Hutchinson D, Piette Integrating physical activity into mental health services for individuals with serious mental illness. Psychiatr Serv 2005;56:324–31
   PubMed Web of Science ®Google Scholar
• Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39(8):1423–34
   PubMed Web of Science ®Google Scholar
• Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diabetes Care 2008;31(Suppl 2):269–77
   PubMed Web of Science ®Google Scholar
• Lemmens VE, Oenema A, Klepp KI, Henriksen HB, Brug J. A systematic review of the evidence regarding efficacy of obesity prevention interventions among adults. Obes Rev 2008;9(5):446–55
   PubMed Web of Science ®Google Scholar
• Roux L, Pratt M, Tengs TO, et al. Cost effectiveness of community-based physical activity interventions. Am J Prev Med 2008;35(6):578–88
   PubMed Web of Science ®Google Scholar